NCT06926244View on ClinicalTrials.gov

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2029

Conditions
IgA Nephropathy (IgAN)
Trial Locations (1)

75013

RECRUITING

Nephrology department, Hospital Pitié - Salpêtrière (ASSISTANCE PUBLIQUE HOPITAUX DE PARIS AP-HP), Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER